glp 1 drugs and parkinson's disease Neuroprotective effects of GLP-1 class in How a 'blockbuster' treatment for
Description
As discussed above, available results have shown that these new pharmacological options, in addition to their anti-hyperglycemic effect, present many cardiorenal and metabolic effects, which can clearly differ according to the timing, dose, and mode of administration, the type and actions of the drugs, and the degree of target organ protection and weight reduction achieved

V., Wu, B., Liu, Y

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats

The opposing effects of GIP and GLP-1 on lipogenesis and lipolysis, respectively, help maintain adipocytes in young and healthy state, fostering higher levels of adiponectin a key adipokine known for its potential antidiabetic, anti-inflammatory, and antiatherogenic properties (185)

doi: 10.14348/molcells.2018.2340 67 ShiLJiYJiangXZhouLXuYLiYet al
